Skip to main content
. Author manuscript; available in PMC: 2015 Mar 4.
Published in final edited form as: J Speech Lang Hear Res. 2010 Jul 19;53(5):1167–1177. doi: 10.1044/1092-4388(2010/09-0154)

Table 1.

Demographic information for the subjects in study. SID refers to subject identifier. Age, education, and PD duration (time since diagnosis) are in years. DBS duration is in the number of months since the stimulators were activated. Levodopa refers to the daily dose in mg. The Unified Parkinson’s Disease Rating Scale motor score (UPDRS III) (Fahn et al., 1987) and the Hoehn and Yahr (H & Y) disease staging scores (Hoehn & Yahr, 1967) are presented for the DBS-ON and DBS-OFF examinations. Both the UPDRS III [t(6) = 2.74; p = 0.034] and the Hoehn and Yahr [t(6) = 2.52; p = 0.045] scores demonstrate significant improvements with DBS-ON. The bottom row provides group means and standard deviations (S.D.).

SID AGE ED PD Duration DBS Duration Levodopa UPDRS III OFF UPDRS III ON H & Y OFF H & Y ON
104 57 16 16 27 400 56.5 55.5 5.0 4.0
106 59 15 10 9 600 27.5 19.0 2.5 2.5
107 62 18 15 2 600 26.0 24.0 2.5 2.0
108 61 14 11 12 600 27.0 9.0 2.0 2.0
109 49 16 9 4 300 23.5 21.5 2.5 2.0
110 62 16 11 56 600 52.5 31.0 4.0 3.0
111 56 18 11 37 400 10.5 4.0 2.0 2.0
Means (S.D.) 58.0 (4.6) 16.1 (1.5) 11.9 (2.6) 21.0 (20) 500 (129) 31.9 (16.5) 23.4 (16.8) 2.9 (1.1) 2.5 (0.8)